Artiva Biotherapeutics Inc (NASDAQ: ARTV) flaunted slowness of -7.97% at $2.77, as the Stock market unbolted on Thursday, before settling in for the price of $3.01 at the close. Taking a more long-term approach, ARTV posted a 52-week range of $1.47-$15.49.
It was noted that the giant of the Healthcare sector posted annual sales growth of -64.01% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -64.01%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.54%. This publicly-traded company’s shares outstanding now amounts to $24.39 million, simultaneously with a float of $12.44 million. The organization now has a market capitalization sitting at $67.66 million. At the time of writing, stock’s 50-day Moving Average stood at $2.84, while the 200-day Moving Average is $3.40.
Artiva Biotherapeutics Inc (ARTV) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Artiva Biotherapeutics Inc industry. Artiva Biotherapeutics Inc’s current insider ownership accounts for 49.08%, in contrast to 53.66% institutional ownership. According to the most recent insider trade that took place on Aug 15 ’25, this organization’s President and CEO sold 25,500 shares at the rate of 2.73, making the entire transaction reach 69,579 in total value, affecting insider ownership by 386,693.
Artiva Biotherapeutics Inc (ARTV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
Artiva Biotherapeutics Inc’s EPS increase for this current 12-month fiscal period is 40.54% and is forecasted to reach -3.23 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 24.31% through the next 5 years, which can be compared against the -64.01% growth it accomplished over the previous five years trading on the market.
In the same vein, ARTV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.09, a figure that is expected to reach -0.87 in the next quarter, and analysts are predicting that it will be -3.23 at the market close of one year from today.
Technical Analysis of Artiva Biotherapeutics Inc (ARTV)
Now, what If we examine the latest scores posted by [Artiva Biotherapeutics Inc, ARTV]. During the last 5-days, its volume was better the volume of 0.31 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 50.98% While, its Average True Range was 44.71.
Raw Stochastic average of Artiva Biotherapeutics Inc (ARTV) in the period of the previous 100 days is set at 58.04%, which indicates a major rise in contrast to 17.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.16 that was lower than 0.23 volatility it exhibited in the past 100-days period.
